(NASDAQ: BLLN) Billiontoone's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.89%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.98%.
Billiontoone's revenue in 2026 is N/A.On average, 10 Wall Street analysts forecast BLLN's revenue for 2026 to be $20,530,084,283, with the lowest BLLN revenue forecast at $19,395,835,648, and the highest BLLN revenue forecast at $21,318,906,834. On average, 10 Wall Street analysts forecast BLLN's revenue for 2027 to be $26,717,856,746, with the lowest BLLN revenue forecast at $25,152,170,471, and the highest BLLN revenue forecast at $28,397,611,822.
In 2028, BLLN is forecast to generate $32,803,979,189 in revenue, with the lowest revenue forecast at $28,830,429,326 and the highest revenue forecast at $35,593,605,293.